RB1CC1 and neoplasm: To investigate why RB1CC1 KO tumours grew faster than control cells even without IKE treatment, we compared the cell proliferation capacity of control and RB1CC1‐KO Bel‐7402 cells and found that RB1CC1 KO cells demonstrated a more accelerated cell proliferation rate than the control cells (Figure S1H).